Is VERV or RYLD a better dividend investment in 2026?

VERV currently yields 17.97% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: VERV offers higher current income.

What is the dividend yield difference between VERV and RYLD?

VERV has a forward dividend yield of 17.97% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 5.83 percentage points.

Home › Compare › VERV vs RYLD

VERV vs RYLD: Dividend Comparison 2026

VERV yields 17.97% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VERV wins by $19.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

VERV

● Live price

17.97%

Share price

$11.13

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$64.4K

Annual income

$5,391.96

Full VERV calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — VERV vs RYLD

📍 VERV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VERV	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VERV + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VERV pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VERV

Annual income on $10K today (after 15% tax)

$1,527.40/yr

After 10yr DRIP, annual income (after tax)

$4,583.17/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, VERV beats the other by $2,383.92/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VERV + RYLD for your $10,000?

VERV: 50%RYLD: 50%

100% RYLD50/50100% VERV

Portfolio after 10yr

$54.5K

Annual income

$3,989.65/yr

Blended yield

7.32%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on VERV right now

VERV

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$18.00

+61.7% upside vs current

Range: $13.00 — $30.00

Altman Z

2.4

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VERV buys

RYLD buys

No recent congressional trades found for VERV or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVERVRYLD

Forward yield	17.97% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$64.4K ✓	$44.5K
Annual income after 10y	$5,391.96 ✓	$2,587.35
Total dividends collected	$34.6K ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: VERV vs RYLD ($10,000, DRIP)

Year	VERV Portfolio	VERV Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$12,497	$1,796.95	$11,914	$1,213.65	+$583.00 → VERV
2	$15,470	$2,098.72	$14,099	$1,351.30	+$1.4K → VERV
3	$18,982	$2,428.12	$16,580	$1,494.55	+$2.4K → VERV
4	$23,094	$2,784.29	$19,384	$1,642.61	+$3.7K → VERV
5	$27,877	$3,165.98	$22,535	$1,794.70	+$5.3K → VERV
6	$33,400	$3,571.61	$26,063	$1,950.00	+$7.3K → VERV
7	$39,737	$3,999.26	$29,995	$2,107.69	+$9.7K → VERV
8	$46,966	$4,446.80	$34,361	$2,266.99	+$12.6K → VERV
9	$55,165	$4,911.86	$39,194	$2,427.12	+$16.0K → VERV
10	$64,419	$5,391.96	$44,525	$2,587.35	+$19.9K → VERV

VERV vs RYLD: Complete Analysis 2026

VERV — Stock

Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Full VERV Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this VERV vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VERV vs SCHD VERV vs JEPI VERV vs O VERV vs KO VERV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.